12th Annual Biomarkers and Clinical Research Congress

12th Annual Biomarkers and Clinical Research Congress is anticipating participants from 40 and more countries across the globe and the two days conference will provoke plenary sessions, Keynote speeches, Poster, and Oral Presentations. This program provides two days of robust discussions on recent advancements and new strategies for development of new materials for global requirements.

Spotlight


OTHER PAST CONFERENCES

AI x PHARMA x HEALTH 2024

March 27, 2024 | Finland

Welcome to learn about artificial intelligence (AI) and its transformative impact on the pharmaceutical industry and healthcare at AI x PHARMA x HEALTH 2024!

International Conference on Antibiotics and Pharmacy Practice (ICAPP-24)

March 7-8, 2024 | Singapore

A premier global platform for the International Conference on Antibiotics and Pharmacy Practice ICAPP welcomes you to its official web page. We’re very happy and proud of our pioneering and innovative renaissance, which has enabled us to introduce and research many revolutionary concepts and philosophies. To be held on 07th - 08th-Mar-2024 at Singapore

SmartLab Exchange Europe 2024

February 21-22, 2024 | Netherlands

The SmartLab Exchange brings together a select group of leading experts from across the smart laboratory space for innovative learning and thought-leadership discussions. This group of R&D/R&D IT, Manufacturing, and QA/QC experts will deliver a number of insightful sessions through inspiring keynotes, in-depth case studies and fireside chats, interactive panels, and intimate roundtables across two-days. In between the exclusive content sessions you will have limitless networking opportunities during peer-to-peer networking and coffee breaks in addition to two drinks receptions. Alongside this our consultative one-to-one business meetings between attendees and solution providers will be carefully scheduled throughout the two-days to meet your specific business needs.

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

May 13-16, 2024 | USA

The 2024 AAPS National Biotechnology Conference, scheduled for May 13-16, 2024, at the Hilton San Francisco Union Square in California, is set to be a pivotal event in the field of biotechnology. This conference aims to bring together experts and researchers to discuss and explore the latest advancements in biotechnology, focusing on the discovery, formulation, and delivery of new modalities. The event is structured around two main tracks, each encompassing multiple themes that address the forefront of biotechnological research and development. Track 1 delves into the advances in discovery, formulation, and delivery of new modalities, particularly in the biologics market. It invites submissions on a wide range of topics, including multi-specific antibodies, oligonucleotides, proteins, nanobodies, genes, RNA, peptides, cell-free manufactured proteins, vaccines, and various types of cells. The track emphasizes the importance of innovative strategies in addressing unmet medical needs through these modalities. The conference also features a second track focusing on novel strategies to advance biotherapeutic development, with themes that cover a broad spectrum of current biotechnological challenges and innovations. This includes preformulation and formulation approaches for biologics, drug delivery systems for new modalities and therapies, and the transformative role of AI/ML in drug discovery and development. Additionally, the conference will address the development strategies for novel targeted therapeutic delivery, advances in analytical and bioanalytical platform technology, and high content bioanalysis. These discussions are expected to cover cutting-edge topics such as targeted drug delivery systems, analytical platform technologies, and the integration of artificial intelligence and machine learning in drug development. Overall, the 2024 AAPS National Biotechnology Conference represents a significant gathering for the biotechnology community, offering a platform for the exchange of ideas and fostering collaborations in the pursuit of advancing biotechnological research and applications.